← FDA DRUG APPROVALS

FDA ANDA · ANDA204264

FLUDEOXYGLUCOSE F18

Sponsor: PHARMALOGIC

APPLICATION
ANDA204264
TYPE
ANDA
ORIGINAL APPROVAL
2014-12-18
LATEST ACTION
2017-12-27
ROUTE
INTRAVENOUS
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FLUDEOXYGLUCOSE F18Discontinued
FLUDEOXYGLUCOSE F-18 20-300mCi/ML · INJECTABLE · INTRAVENOUS

Approval history

2017-12-27Manufacturing (CMC) · Supplement 1 · unknownAP
2014-12-18UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →